Int. J. Mol. Sci. 2011, 12(11), 8161-8180; doi:10.3390/ijms12118161
Article

In Silico Identification of Structure Requirement for Novel Thiazole and Oxazole Derivatives as Potent Fructose 1,6-Bisphosphatase Inhibitors

Ming Hao 1,† email, Xiaole Zhang 2,† email, Hong Ren 3,4 email, Yan Li 1,* email, Shuwei Zhang 1 email, Fang Luo 5 email, Mingjuan Ji 5 email, Guohui Li 4 email and Ling Yang 6 email
1 Department of Materials Science and Chemical Engineering, Dalian University of Technology, Dalian, Liaoning, 116023, China 2 Department of Mathematical Sciences, Dalian University of Technology, Dalian, Liaoning, 116023, China 3 Department of Ophthalmology, Qi Lu Hospital, Medical School of Shandong University, Jinan, 250012, China 4 Laboratory of Molecular Modeling and Design, State Key Laboratory of Molecular Reaction Dynamics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian, 116023, China 5 College of Chemistry and Chemical Engineering, Graduate School of the Chinese Academy of Sciences, Beijing, 100049, China 6 Laboratory of Pharmaceutical Resource Discovery, Dalian Institute of Chemical Physics, Graduate School of the Chinese Academy of Sciences, Dalian, Liaoning, 116023, China † These authors contributed equally to this work.
* Author to whom correspondence should be addressed.
Received: 8 October 2011; in revised form: 10 November 2011 / Accepted: 16 November 2011 / Published: 18 November 2011
(This article belongs to the Section Physical Chemistry, Theoretical and Computational Chemistry)
PDF Full-text Download PDF Full-Text [3812 KB, uploaded 18 November 2011 12:10 CET]
Abstract: Fructose 1,6-bisphosphatase (FBPase) has been identified as a drug discovery target for lowering glucose in type 2 diabetes mellitus. In this study, a large series of 105 FBPase inhibitors were studied using a combinational method by 3D-QSAR, molecular docking and molecular dynamics simulations for a further improvement in potency. The optimal 3D models exhibit high statistical significance of the results, especially for the CoMFA results with rncv2, q2 values of 0.986, 0.514 for internal validation, and rpred2, rm2 statistics of 0.902, 0.828 statistics for external validation. Graphic representation of the results, as contoured 3D coefficient plots, also provides a clue to the reasonable modification of molecules. (1) Substituents with a proper length and size at the C5 position of the thiazole core are required to enhance the potency; (2) A small and electron-withdrawing group at the C2 position linked to the thiazole core is likely to help increase the FBPase inhibition; (3) Substituent groups as hydrogen bond acceptors at the C2 position of the furan ring are favored. In addition, the agreement between 3D-QSAR, molecular docking and molecular dynamics simulation proves the rationality of the developed models. These results, we hope, may be helpful in designing novel and potential FBPase inhibitors.
Keywords: 3D-QSAR; molecular dynamics; FBPase inhibitors; CoMFA; CoMSIA

Supplementary Files

Article Statistics

Click here to load and display the download statistics.

Cite This Article

MDPI and ACS Style

Hao, M.; Zhang, X.; Ren, H.; Li, Y.; Zhang, S.; Luo, F.; Ji, M.; Li, G.; Yang, L. In Silico Identification of Structure Requirement for Novel Thiazole and Oxazole Derivatives as Potent Fructose 1,6-Bisphosphatase Inhibitors. Int. J. Mol. Sci. 2011, 12, 8161-8180.

AMA Style

Hao M, Zhang X, Ren H, Li Y, Zhang S, Luo F, Ji M, Li G, Yang L. In Silico Identification of Structure Requirement for Novel Thiazole and Oxazole Derivatives as Potent Fructose 1,6-Bisphosphatase Inhibitors. International Journal of Molecular Sciences. 2011; 12(11):8161-8180.

Chicago/Turabian Style

Hao, Ming; Zhang, Xiaole; Ren, Hong; Li, Yan; Zhang, Shuwei; Luo, Fang; Ji, Mingjuan; Li, Guohui; Yang, Ling. 2011. "In Silico Identification of Structure Requirement for Novel Thiazole and Oxazole Derivatives as Potent Fructose 1,6-Bisphosphatase Inhibitors." Int. J. Mol. Sci. 12, no. 11: 8161-8180.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert